• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept.

作者信息

Ravishankar Hema, Patil Preeti, Samel Ashwini, Petereit Hans-Ulrich, Lizio Rosario, Iyer-Chavan Jayanthi

机构信息

Degussa India Pvt Ltd, Research Centre India, 1st floor, Krislon House, Sakivihar Road, Sakinaka, Mumbai-400072, India.

出版信息

J Control Release. 2006 Mar 10;111(1-2):65-72. doi: 10.1016/j.jconrel.2005.12.007. Epub 2006 Jan 30.

DOI:10.1016/j.jconrel.2005.12.007
PMID:16446006
Abstract

A modulated release, multiunit oral drug delivery technology using a system based on ionic interactions of anions of salts with quaternary ammonium ions of the ammoniomethacrylate polymer is described. The system consisted of a drug layered, EUDRAGIT NE-coated salt core which was further coated with EUDRAGIT RS. The relative effects of different anions on the polymer permeability have been investigated by studying their influence on the in vitro drug release. A prototype formulation of metoprolol succinate using this technology was developed and the drug release from the formulation was adjusted to have a release profile which would match the circadian rhythm i.e. a higher amount of drug would be available after an initial lower release (accelerated type of release). The formulation was tested in vivo in 12 healthy human volunteers in an open label, randomized, two-treatment, two-period, single dose crossover bio-study with reference formulation Beloc-zok. The in vivo release demonstrated that compared to the reference, a higher amount of drug was available in the plasma from the 7th hour onwards. A higher AUC of the drug was also observed compared to the reference formulation. An in vitro-in vivo correlation was attempted to identify a bio-relevant in vitro dissolution medium for the formulation.

摘要

相似文献

1
Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept.
J Control Release. 2006 Mar 10;111(1-2):65-72. doi: 10.1016/j.jconrel.2005.12.007. Epub 2006 Jan 30.
2
Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.盐酸二甲双胍缓释微丸的制备及体内外评价
Eur J Pharm Biopharm. 2006 Oct;64(2):185-92. doi: 10.1016/j.ejpb.2006.04.004. Epub 2006 May 10.
3
Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.多层缓释微丸制剂和渗透系统中单剂量哌甲酯的相对生物利用度:健康年轻成年人的双向交叉研究。
Clin Ther. 2008 Jan;30(1):59-69. doi: 10.1016/j.clinthera.2008.01.002.
4
Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.柠檬酸一水合物作为熔融挤出型骨架片中的释放调节剂。
Int J Pharm. 2008 Sep 1;361(1-2):158-68. doi: 10.1016/j.ijpharm.2008.05.035. Epub 2008 Jun 5.
5
In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.含灰黄霉素速崩冻干干乳剂片的体外和体内评价
Eur J Pharm Sci. 2007 Sep;32(1):58-68. doi: 10.1016/j.ejps.2007.05.114. Epub 2007 Jun 7.
6
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.400毫克阿昔洛韦的两种口服混悬剂和两种口服片剂剂型的生物利用度:在健康墨西哥成年受试者中进行的两项单剂量、开放标签、随机、两期交叉比较。
Clin Ther. 2007 Jun;29(6):1146-52. doi: 10.1016/j.clinthera.2007.06.007.
7
Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.基于渗透技术的盐酸曲马多缓释制剂的研发与生物药剂学评价
Acta Pharm. 2009 Mar;59(1):15-30. doi: 10.2478/v10007-009-0010-2.
8
Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.两种市售硝苯地平缓释制剂的比较:一项探索性临床食物相互作用研究。
Clin Ther. 2008 Jan;30(1):48-58. doi: 10.1016/j.clinthera.2008.01.001.
9
A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.一项在健康韩国成年人中进行的他克莫司两种口服制剂的随机、开放标签、两期交叉生物利用度研究。
Clin Ther. 2007 Jan;29(1):154-62. doi: 10.1016/j.clinthera.2007.01.016.
10
Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.两种萘普生钠/对乙酰氨基酚口服片剂和两种口服混悬剂的生物利用度:在健康墨西哥成年受试者中进行的单剂量、随机、开放标签、两阶段交叉比较。
Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002.

引用本文的文献

1
Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling.基于实验设计和生理药剂学模型的美托洛尔缓释微型片的研发
Pharmaceutics. 2022 Apr 19;14(5):892. doi: 10.3390/pharmaceutics14050892.
2
Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating.相分离控释薄膜包衣多介质中的聚合物分布与机理转变
Pharmaceutics. 2019 Feb 14;11(2):80. doi: 10.3390/pharmaceutics11020080.
3
Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.
预防性治疗偏头痛药物的药代动力学变异性。
CNS Drugs. 2017 May;31(5):389-403. doi: 10.1007/s40263-017-0430-3.
4
Design and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrate.酒石酸美托洛尔新型控释长效给药系统的设计与体外评价
Res Pharm Sci. 2016 Jan-Feb;11(1):81-92.
5
Model drug as pore former for controlled release of water-soluble metoprolol succinate from ethylcellulose-coated pellets without lag phase: opportunities and challenges.以模型药物作为成孔剂实现无水溶性琥珀酸美托洛尔从乙基纤维素包衣微丸的控释且无滞后阶段:机遇与挑战
AAPS PharmSciTech. 2015 Feb;16(1):35-44. doi: 10.1208/s12249-014-0197-5. Epub 2014 Aug 28.
6
Novel/conceptual floating pulsatile system using high internal phase emulsion based porous material intended for chronotherapy.新型/概念性浮动脉动系统,使用基于高内相乳液的多孔材料,旨在用于时间治疗。
AAPS PharmSciTech. 2009;10(4):1368-80. doi: 10.1208/s12249-009-9331-1. Epub 2009 Nov 20.
7
Modulation and optimization of drug release from uncoated low density porous carrier based delivery system.基于未包衣低密度多孔载体递送系统的药物释放调控与优化
AAPS PharmSciTech. 2009;10(2):547-58. doi: 10.1208/s12249-009-9239-9. Epub 2009 May 8.